1-5 of 5
Rod Humerickhouse
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B10: Studying BCL-2 dependence using BH3 profiling in a phase 2 clinical trial of ABT-199 in acute myeloid leukemia.

Leah Hogdal, Brenda Chyla, Evelyn McKeegan, Joel Leverson, Jalaja Potluri, Rod Humerickhouse, Mabry Mack, Daniel DeAngelo, Ilene Galinsky, Richard Stone, Anthony Letai
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17_Supplement): B10.
https://doi.org/10.1158/1557-3265.HEMMAL14-B10
Published: 19 August 2015
View article titled, Abstract B10: Studying BCL-2 dependence using BH3 profiling in a phase 2 clinical trial of ABT-199 in acute myeloid leukemia.
Journal Articles

Dynamic contrast enhanced MRI (DCE-MRI) for assessment of effects of anti-angiogenic therapy: Comparison of the transfer constant (Ktrans) to blood flow and permeability derived by a distributed parameter model

Choon Hua Thng, Tong San Koh, Septian Hartono, Helmut Rumpel, James Khoo, Albert Low, Ai Bee Ong, Norita Sukri, Bee Choo Tai, Ross Soo, Rod Humerickhouse, Boon Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): A41.
Published: 15 August 2014
View article titled, Dynamic contrast enhanced MRI (DCE-MRI) for assessment of effects of anti-angiogenic therapy: Comparison of the transfer constant (Ktrans) to blood flow and permeability derived by a distributed parameter model
Journal Articles

Characterization of human circulating endothelial cells to monitor response to antitumor therapy in human clinical trials

Evelyn M. McKeegan, Dawn Carlson, Raymond Knight, Milagros Colon-Lopez, Peter Devries, Rod Humerickhouse, Rick Lesniewski
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): PR-5.
Published: 15 August 2014
View article titled, Characterization of human circulating endothelial cells to monitor response to antitumor therapy in human clinical trials
Journal Articles

Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies

Christopher W. Ryan, Nicholas J. Vogelzang, Everett E. Vokes, Hedy L. Kindler, Samir D. Undevia, Rod Humerickhouse, Amy K. André, Qiang Wang, Robert A. Carr, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4406–4411.
https://doi.org/10.1158/1078-0432.CCR-04-0083
Published: 06 July 2004
View article titled, Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies
Open the PDF for Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies in another window
Journal Articles

Irinotecan Activation by Human Carboxylesterases in Colorectal Adenocarcinoma Cells

Michael H. Wu, Bingfang Yan, Rod Humerickhouse, M. Eileen Dolan
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2696–2700.
Published: 01 August 2002
View article titled, Irinotecan Activation by Human Carboxylesterases in Colorectal Adenocarcinoma Cells
Open the PDF for Irinotecan Activation by Human Carboxylesterases in Colorectal Adenocarcinoma Cells in another window